M&A / Deals UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies PharmaTimesPartnership builds on existing collaboration and adds two new UCBnominated projectsOncologyRead full story pharminent May 7, 2026 (Last updated: May 8, 2026) PharmaTimes Partnership builds on existing collaboration and adds two new UCBnominated projects Oncology Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturingNext: Roche buys AI-powered diagnostics player PathAI Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
